Test: Difference between revisions
From haematologyetc.co.uk
No edit summary |
No edit summary |
||
Line 44: | Line 44: | ||
|colspan="1" style = "background:#006699;"| | |colspan="1" style = "background:#006699;"| | ||
|colspan="1" style = "font-size:80%;"|- | |colspan="1" style = "font-size:80%;"|- | ||
|colspan="1" style = "font-size:84%;"| | |colspan="1" style = "font-size:84%;"|Generally expressed | ||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:black;" |CD200 | |colspan="1" style = "font-size:90%; color:black;" |CD200 | ||
|colspan="1" style = "background:#66e0ff;"| | |colspan="1" style = "background:#66e0ff;"| | ||
|colspan="1" style = "font-size:80%;"|- | |colspan="1" style = "font-size:80%;"|- | ||
|colspan="1" style = "font-size:84%;"| | |colspan="1" style = "font-size:84%;"|Detected infrequently | ||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:black;" |FMC7 | |colspan="1" style = "font-size:90%; color:black;" |FMC7 | ||
|colspan="1" style = "background:#006699;"| | |colspan="1" style = "background:#006699;"| | ||
|colspan="1" style = "font-size:80%;"| | |colspan="1" style = "font-size:80%;"| | ||
|colspan="1" style = "font-size:80%;"| | |colspan="1" style = "font-size:80%;"|Generally expressed | ||
|- | |- | ||
!colspan="4" style = "font-size:90%; background:#DAE8F2"|Other relevant markers | !colspan="4" style = "font-size:90%; background:#DAE8F2"|Other relevant markers | ||
Line 71: | Line 71: | ||
|colspan="1" style = "background:#004466;"| | |colspan="1" style = "background:#004466;"| | ||
|colspan="1" style = "font-size:80%;"|- | |colspan="1" style = "font-size:80%;"|- | ||
|colspan="1" style = "font-size:84%;"| | |colspan="1" style = "font-size:84%;"|Expect expression | ||
|- | |- | ||
|colspan="1" style = "font-size:90%; color:black;" |CD25 | |colspan="1" style = "font-size:90%; color:black;" |CD25 |
Revision as of 14:01, 12 July 2023
Background to flow cytometric diagnosis
This is an uncommon diagnosis by flow cytometry as DLBCL cells generally circulate and involve bone marrow only at only a late stage in disease (ofetn when a diagnosis has already been made). However, occasionally these cases can present as a new diagnosis by blood or marrow and can be difficult as marker expression is often variable between cases.
Immunophenotype of DLBCL | |||
---|---|---|---|
Major markers useful in CLL diagnosis | |||
Marker | Freq | Level | Comment |
CD19 | - | Generally CD19 will be expressed | |
κ/λ | Light chain retriction usually detected | ||
CD5 | - | Uncommon but seen in some cases | |
CD23 | - | Infrequent but reported | |
CD79b | - | Generally expressed | |
CD200 | - | Detected infrequently | |
FMC7 | Generally expressed | ||
Other relevant markers | |||
CD10 | - | Expression may be seen | |
CD11C | - | ||
CD20 | - | Expect expression | |
CD25 | - | ||
CD38 | - | ||
CD43 | - | ||
CD103 | - | ||
CD138 | - |
Key to table:
Key to colour code for expression frequency Click for link
Key to expression strength code and use Click for link